Search Results 11-20 of 17058 for Plasmacytoma

  1. A Study to Explore Quality of Life According to Treatment Plan for Patients with Multiple Myeloma Following Autologous Stem Cell Transplant - Mayo Clinic

    ... plasmacytoma; Monoclonal protein present in serum and/or urine. Myeloma-related organ dysfunction 1 or more. (C) Calcium elevation in blood. Serum calcium >1mg ...

  2. A Study of Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients with Previously Treated Multiple Myeloma or Plasma Cell Leukemia - Mayo Clinic

    Previously treated myeloma currently with measurable disease. Extramedullary disease defined as Plasmacytoma outside bone marrow that is not contiguous with ...

  3. Study Evaluating the Safety and Effectiveness of JCARH125 in Subjects with Relapsed and/or Refractory Multiple Myeloma (EVOLVE) - Mayo Clinic

    Subjects with solitary plasmacytoma; active or history of plasma cell leukemia (PCL); Waldenstrom's macroglobulinemia; POEMS syndrome (Polyneuropathy ...

  4. Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL Study - Mayo Clinic

    * Measurable plasmacytoma \[at least one lesion that has a single diameter of ≥2 cm on positron emission tomography (PET)-computed tomography (CT) scan\] * ...

  5. Multiple myeloma: Its evolution, treatment and the quest to catch it early

    March is Multiple Myeloma Awareness Month. Multiple myeloma is a cancer of a type of white blood cell called a plasma cell in the bone marrow.

  6. Publications - Prashant Kapoor, M.D. - Mayo Clinic

    Solitary plasmacytoma: single-institution experience, and systematic review and meta-analysis of clinical outcomes. Blood Adv. 2025 Apr 08; 9(7):1559-1570 ...

  7. Acute myelogenous leukemia - Doctors and departments - Mayo Clinic

    Learn about this cancer that forms in the bone and bone marrow. Treatments include medications and bone marrow transplant.

  8. Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Measurable plasmacytoma; if plasmacytoma measurement is the only measurable disease, subject eligibility must be reviewed with lead principal investigator ...

  9. A Study to Evaluate the Effectiveness and Safety of CAEL-101 in Patients with Mayo Stage IIIa AL Amyloidosis

    ... plasmacytoma AND one or more of the following CRAB features: a. Evidence of end organ damage that can be attributed to the underlying plasma cell ...

  10. Cyclophosphamide, Ixazomib, and Dexamethasone in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma - Mayo Clinic

    Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 3 x ULN; Prior therapy for the treatment of solitary plasmacytoma is permitted, but ...